Silphium Asset Management’s Medicines Co MDCO Stock Holding History

Silphium Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-41,969	Closed	-$3.56M	–	65
2019 Q4	$3.56M	Buy	+41,969	New	+$2.8M	1.87%	15

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Silphium Asset Management's MDCO Position: Q1 2020 in Review

Silphium Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 41,969 shares — an estimated $3.56M sold.

Silphium Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $3.56M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Silphium Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Silphium Asset Management sold 41,969 Medicines Co shares in Q1 2020, an estimated $3.56M.
Silphium Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Silphium Asset Management's Medicines Co position peaked at $3.56M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Silphium Asset Management's 13F filing for Q1 2020, filed 30 Jan 2025.